Robbert Boudewijns

Title: Robbert Boudewijns: Innovator in Vaccine Development

Introduction

Robbert Boudewijns is a notable inventor based in Essen, Belgium. He has made significant contributions to the field of vaccine development, particularly through his innovative work with flaviviruses. His research focuses on creating effective vaccines that can combat various viral infections.

Latest Patents

Robbert Boudewijns holds a patent for "Live-attenuated flaviruses with heterologous antigens." This invention relates to polynucleotides that comprise the sequence of a flavivirus, which is preceded by a sequence encoding an N-terminal part of a flavivirus capsid protein, an immunogenic protein, or a part thereof that includes an immunogenic peptide and a 2A cleaving peptide. The patent also covers the virus encoded by such sequences and their use as vaccines.

Career Highlights

Robbert Boudewijns is affiliated with Katholieke Universiteit Leuven, where he conducts his research and development work. His career has been marked by a commitment to advancing the understanding and application of viral immunology.

Collaborations

He has collaborated with notable colleagues such as Kai Dallmeier and Johan Neyts, contributing to a rich environment of innovation and research in the field of virology.

Conclusion

Robbert Boudewijns is a prominent figure in the realm of vaccine innovation, with a focus on flavivirus research. His contributions are paving the way for new advancements in vaccine technology.